FEATURED EVENT: New standards in protecting high-risk patients: learning from the ONTARGET^® programme

The annual congress of the European Society of Cardiology (ESC) was held in Munich, Germany from 30th August to 3rd September 2008. During the first of two Boehringer Ingelheim and Bayer Schering Pharma satellite symposia, entitled “New standards in protecting high-risk patients: learning from the ONTARGET^® programme”, renowned international experts discussed the implications of the ONTARGET^® trial results on clinical practice. The entire session is now available as a webcast under the following link.

Click here for more information.